No Known Link Between New Obesity Drugs and Suicide, European Medicines Agency Finds

Health News

No Known Link Between New Obesity Drugs and Suicide, European Medicines Agency Finds
European Medicines AgencyObesity DrugsSuicide
  • 📰 GlobalCalgary
  • ⏱ Reading Time:
  • 23 sec. here
  • 11 min. at publisher
  • 📊 Quality Score:
  • News: 43%
  • Publisher: 61%

The European Medicines Agency regulatory committee concludes that there is no known tie between a new class of obesity drugs and suicide. This follows previous findings by the U.S. Food and Drug Administration and a federally funded U.S. study.

The European Medicines Agency regulatory committee announced the results of its review on Friday. It’s the latest group to conclude there’s no known tie between a new class of obesity drugs and suicide.

In January, the U.S. Food and Drug Administration said a preliminary review showed no evidence of such a link, though the agency said it could not rule out that “a small risk may exist” and that it would continue to study the issue. A federally funded U.S. study also found that people taking, the medication in Ozempic and Wegovy, had a lower risk of suicidal thoughts than those taking older medications to treat diabetes and obesity.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

GlobalCalgary /  🏆 50. in CA

European Medicines Agency Obesity Drugs Suicide FDA U.S. Study Diabetes Post-Marketing Data Mounjaro Zepbound

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

2024 NHL Free Agency: Top 10 European UFAs2024 NHL Free Agency: Top 10 European UFAsThere’s no Artemi Panarin this year, but if you need depth, you’ve got options.
Read more »

EU targets Zoetis in antitrust investigation over dog medicinesEU targets Zoetis in antitrust investigation over dog medicinesExplore stories from Atlantic Canada.
Read more »

Doping-Valieva's cocktail of medicines raises concerns around supplement dangersDoping-Valieva's cocktail of medicines raises concerns around supplement dangersExplore stories from Atlantic Canada.
Read more »

Mitsui and Rohto to buy $594 million Chinese medicines company Eu Yan SangMitsui and Rohto to buy $594 million Chinese medicines company Eu Yan SangExplore stories from Atlantic Canada.
Read more »

Mitsui and Rohto to buy $594 million Chinese medicines company Eu Yan SangMitsui and Rohto to buy $594 million Chinese medicines company Eu Yan SangExplore stories from Atlantic Canada.
Read more »

What is known about Kate's cancer diagnosisWhat is known about Kate's cancer diagnosisKate, the Princess of Wales , has disclosed that she has cancer and is undergoing chemotherapy — though in a video announcement Friday, she did not say what kind of cancer or reveal details of her treatment.
Read more »



Render Time: 2025-02-13 10:27:44